Characterization of baseline polybacterial versus monobacterial infections in three randomized controlled bacterial conjunctivitis trials and microbial outcomes with besifloxacin ophthalmic suspension 0.6.

DeCory, Heleen H; Sanfilippo, Christine M; Proskin, Howard M; Blondeau, Joseph M

DeCory, Heleen H; Sanfilippo, Christine M; Proskin, Howard M; Blondeau, Joseph M.

Affiliation

DeCory HH; Medical Affairs, Bausch + Lomb, Rochester, New York, United States of America.
Sanfilippo CM; Medical Affairs, Bausch + Lomb, Rochester, New York, United States of America.
Proskin HM; Howard M. Proskin & Associates, Rochester, New York, United States of America.
Blondeau JM; Clinical Microbiology, Royal University Hospital, Saskatoon, Saskatchewan, Canada.

PLoS One ; 15(8): e0237603, 2020.

Article in En | MEDLINE | ID: mdl-32841261

Subject(s)

Anti-Bacterial Agents/therapeutic use; Azepines/therapeutic use; Bacteria/classification; Bacteria/drug effects; Conjunctivitis, Bacterial/drug therapy; Fluoroquinolones/therapeutic use; Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Conjunctivitis, Bacterial/microbiology; Conjunctivitis, Bacterial/pathology; Double-Blind Method; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Prognosis; Prospective Studies; Young Adult

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Plantas_medicinales Main subject: Azepines / Bacteria / Conjunctivitis, Bacterial / Fluoroquinolones / Anti-Bacterial Agents Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: PLoS One Year: 2020 Type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google